Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii. 2020

Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
Centro de Desenvolvimento Tecnológico (CDTec), Programa de Pós-Graduação em Biotecnologia (PPGB), Universidade Federal de Pelotas (UFPel), Núcleo de Biotecnologia, Capão do Leão, RS, Brazil.

Antimicrobial resistance is increasing around the world and the search for effective treatment options, such as new antibiotics and combination therapy is urgently needed. The present study evaluates oregano essential oil (OEO) antibacterial activities against reference and multidrug-resistant clinical isolates of Acinetobacter baumannii (Ab-MDR). Additionally, the combination of the OEO and polymyxin B was evaluated against Ab-MDR. Ten clinical isolates were characterized at the species level through multiplex polymerase chain reaction (PCR) for the gyrB and blaOXA-51-like genes. The isolates were resistant to at least four different classes of antimicrobial agents, namely, aminoglycosides, cephems, carbapenems, and fluoroquinolones. All isolates were metallo-β-lactamase (MβL) and carbapenemase producers. The major component of OEO was found to be carvacrol (71.0%) followed by β-caryophyllene (4.0%), γ-terpinene (4.5%), p-cymene (3,5%), and thymol (3.0%). OEO showed antibacterial effect against all Ab-MDR tested, with minimum inhibitory concentrations (MIC) ranging from 1.75 to 3.50 mg mL-1. Flow cytometry demonstrated that the OEO causes destabilization and rupture of the bacterial cell membrane resulting in apoptosis of A. baumannii cells (p < 0.05). Synergic interaction between OEO and polymyxin B (FICI: 0.18 to 0.37) was observed, using a checkerboard assay. When combined, OEO presented until 16-fold reduction of the polymyxin B MIC. The results presented here indicate that the OEO used alone or in combination with polymyxin B in the treatment of Ab-MDR infections is promising. To the best of our knowledge, this is the first report of OEO and polymyxin B association against Ab-MDR clinical isolates.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009822 Oils, Volatile Oils which evaporate readily. The volatile oils occur in aromatic plants, to which they give odor and other characteristics. Most volatile oils consist of a mixture of two or more TERPENES or of a mixture of an eleoptene (the more volatile constituent of a volatile oil) with a stearopten (the more solid constituent). The synonym essential oils refers to the essence of a plant, as its perfume or scent, and not to its indispensability. Essential Oil,Oil, Essential,Oil, Volatile,Oils, Essential,Volatile Oil,Essential Oils,Volatile Oils
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000081007 Cymenes A subclass of monoterpenes that contain a single benzene ring structure with an isopropyl group and one or more methyl groups. Benzenoid Menthane,Benzenoid Menthanes,Cymene,Menthane, Benzenoid,Menthanes, Benzenoid
D000081223 Polycyclic Sesquiterpenes Sesquiterpenes that contain two or more ring structures Caryophyllane,Caryophyllane Derivative,Caryophyllane Derivatives,Caryophyllanes,Eremophilane,Eremophilane Derivative,Eremophilane Derivatives,Eremophilanes,Polycyclic Sesquiterpene,Valerane,Valerane Derivative,Valerane Derivatives,Valeranes,Derivative, Caryophyllane,Derivative, Eremophilane,Derivative, Valerane,Derivatives, Caryophyllane,Derivatives, Eremophilane,Derivatives, Valerane,Sesquiterpene, Polycyclic,Sesquiterpenes, Polycyclic
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
March 2004, Antimicrobial agents and chemotherapy,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
February 2006, Antimicrobial agents and chemotherapy,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
May 2019, International journal of antimicrobial agents,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
January 2012, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
April 2023, The Journal of antimicrobial chemotherapy,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
June 2016, The Journal of antibiotics,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
October 2022, The Journal of antibiotics,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
June 2016, Scientific reports,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Suélen Cavalheiro Amaral, and Beatriz Bohns Pruski, and Stella Buchhorn de Freitas, and Suzane Olachea Allend, and Marcos Roberto Alves Ferreira, and Clóvis Moreira, and Daniela Isabel Brayer Pereira, and Antonio Sergio Varela Junior, and Daiane Drawanz Hartwig
March 2019, Journal of medical microbiology,
Copied contents to your clipboard!